 |
1 Product |  |
0 Diseases | | 1 Product |
|
0 Trials |  |
2 News |  |
- | T-Guard (SPV-T3a-RTA/WT1-RTA) / Xenikos
Trial completion, Trial primary completion date: Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD (clinicaltrials.gov) - Jun 7, 2017
P1/2, N=20, Completed, Sponsor: Xenikos
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Sep 2016
- | T-Guard (SPV-T3a-RTA/WT1-RTA) / Xenikos
New P1/2 trial: Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD (clinicaltrials.gov) - Jan 2, 2014
P1/2, N=20, Recruiting, Sponsor: Xenikos